Alertness-Enhancing Drugs as a Countermeasure to Fatigue in Irregular Work Hours

References

• Åkerstedt T. Work hours, sleepiness and the mechanism. J Sleep Res 1995; 4(Suppl 2)15–22
   PubMed Web of Science ®Google Scholar
• Dinges D F. An overview of sleepiness and accidents. J Sleep Res 1995; 4(Suppl 2)4–14
   PubMed Web of Science ®Google Scholar
• Knauth P. Design of shiftwork systems. Shiftwork. Problems and solutions, W P Colquhoun, G Costa, S Folkard, P Knauth. Peter Lang GmbH, Frankfurt am Main 1996; 155–73
   Google Scholar
• Rosekind M R, Smith R M, Miller D L, Webbon L L, Co E L, Gregory K B, Gander P H, Lebacqz J V. Alertness management: strategic naps in operational settings. J Sleep Res 1995; 4(Suppl 2)62–6
   PubMed Web of Science ®Google Scholar
• Czeisler C A, Dijk D J. Use of bright light to treat maladaptation to night shift work and circadian rhythm sleep disorders. J Sleep Res 1995; 4(Suppl 2)70–3
   PubMed Web of Science ®Google Scholar
• Weiner N. Norepinephrine, epinephrine and sympathomimetic amines. Macmillan, New York 1985; 167
   Google Scholar
• Groves P M, Rebec G V. Biochemistry and behavior: some central actions of amphetamine and antipsychotic drugs. Annu Rev Psychol 1976; 27: 91–127
   PubMed Web of Science ®Google Scholar
• Rambert F A, Pessonnier J, Duteil J. Modafinil-, amphetamine- and methylphenidate induced hyperactivities in mice involve different mechanisms. Eur J Pharmacol 1990; 183: 455–6
   Web of Science ®Google Scholar
• Angrist B, Corwin J, Bartlik B, Cooper T. Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects. Biol Psychiatry 1987; 22: 1357–68
   PubMed Web of Science ®Google Scholar
• Gershon E S, Nurnberger J N, Sitaram N, Gillin J C. Pharmacogenetics and the pharmacological challenge strategy in clinical research. Progress in neuropsychopharmacology, B Saletu. Pergamon Press, Oxford 1979; 75–83
   Google Scholar
• Spiegel R. Effects of amphetamines on performance and on poly graphic sleep parameters in man. Adv Biosci 1979; 21: 189–201
   Google Scholar
• Newhouse P A. The effects of D-amphetamine on arousal, cognition and mood after prolonged sleep deprivation. Neuropsychopharmacology 1989; 92: 153–64
   Google Scholar
• Pigeau R, Naitoh P, Buguet A, McCann C, Baranski J, Taylor M, Thompson M, Mack I. Modafinil, D-amphetamine and placebo during 64 hours of sustained mental work. Effects on mood and performance. J Sleep Res 1995, in press
   Web of Science ®Google Scholar
• Senechal P K. Flight surgeon support of combat operations at RAF Upper Heyford. Aviat Space Environ Med 1988; 59: 776–7
   PubMed Web of Science ®Google Scholar
• Emonson D L, Vanderbeek R D. The use of amphetamines in U.S. Air Force tactical operations during desert shield and storm. Aviat Space Environ Med 1995; 66: 260–3
   PubMed Web of Science ®Google Scholar
• Penatar D, Schelling A, Sealock J, Sing H, Thorne D, Thomas M, Fertig J, New-House P, Belenky G. Recovery sleep following amphetamine reversal of performance decrements during sleep deprivation. Sleep Res 1990; 19: 83
   Google Scholar
• Saletu B, Frey R, Krupka M, Anderer P, Grunberger J, Barbanoj M J. Different effects of the new central adrenergic agonist modafinil and D-amphetamine on sleep and early morning behaviour in elderlies. Arzneimittelforschung 1989; 39: 1268–73
   PubMed Web of Science ®Google Scholar
• Buguet A, Montmayeur A, Pigeau R, Naitoh P. Modafinil, D-amphetamine and placebo during 64 hours of sustained mental work. Effects on two nights of recovery sleep. J Sleep Res 1995; 4: 229–41
   PubMed Web of Science ®Google Scholar
• Oswald I. Drugs and sleep. Pharmacol Rev 1968; 20: 273–303
   PubMed Web of Science ®Google Scholar
• Oswald I. Sleep studies in clinical pharmacology. Br J Clin Pharmacol 1980; 10: 317–26
   PubMed Web of Science ®Google Scholar
• Gillin J C, Swerdlow N, Darko D, Lam R, Gierz M, Berkowitz A. Depression ratings and all night EEG studies during acute withdrawal in cocaine and amphetamine addicts. Sleep Res 1989; 18: 178
   Google Scholar
• Davis J M. A two factor theory of schizophrenia. J Psychiatr Res 1974; 11: 25–9
   PubMed Web of Science ®Google Scholar
• Simon P, Panissaud C, Costentin J. The stimulant effect of Modafinil on wakefulness is not associated with an increase of anxiety in mice. Psychopharmacology 1994; 114: 597–600
   PubMed Web of Science ®Google Scholar
• Schuster C, Fischmann M W. Amphetamine toxicity: behavioral and neuropathological indexes. Fed Proc 1975; 34: 1845–51
   PubMedGoogle Scholar
• Angrist B, Lee H K, Gershon S. The antagonism of amphetamine-induced symptomatology by a neuroleptic. Am J Psychiatry 1974; 131: 817–9
   PubMed Web of Science ®Google Scholar
• Dews P B. Behavioral effects of caffeine. Caffeine—perspectives from recent research. Springer-Verlag, New York 1984; 86–103
   Google Scholar
• Bennington J H, Kodali S K, Heller H C. Al adenosine receptor stimulation mimics changes in non-REM sleep EEG slow-wave activity. Sleep Res 1993; 22: 4
   Google Scholar
• Seidel W F, et al. NREM sleep homeostasis in rats after caffeine or methamphet-amine. Sleep Res 1994; 23: 82
   Google Scholar
• Rainnie D G, et al. Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal. Science 1994; 263: 689–92
   PubMed Web of Science ®Google Scholar
• Bonnet M H, Arand D L. The effect of chronic caffeine use on mood and personality. Sleep Res 1990; 20: 172
   Google Scholar
• Bonnet M H, Arand D L. Chronic caffeine effects on sleep, metabolism and daytime alertness. Sleep Res 1990; 20: 211
   Google Scholar
• Lieberman H E, Wurtman R J, Emde G G, Coviella I LG. The effects of low doses of caffeine on human performance and mood. Psychopharmacology 1987; 92(308)12
   Google Scholar
• Kuznicki J T, Turner L S. The effects of caffeine on caffeine users and non-users. Physiol Behav 1986; 37: 397–408
   PubMed Web of Science ®Google Scholar
• Lorist M M, Snel J, Kok A, Mulder G. Influence of caffeine on selective attention in well rested and fatigued subjects. Psychophysiology 1994; 31: 525–34
   PubMed Web of Science ®Google Scholar
• Walsh J K, Muehlbach M J, Schweitzer P K. Hypnotics and caffeine as countermea-sures for shiftwork-related sleepiness and sleep disturbance. J Sleep Res 1995; 4(Suppl 2)80–3
   PubMed Web of Science ®Google Scholar
• Penatar D, Thorne D R. Caffeine reversal of sleep deprivation effects. Sleep Res 1990; 20: 74
   Google Scholar
• Rosenthal L, Roehrs T, Zwyghhuizen-Doorenbos A, Plath D, Roth T. Alerting effects of caffeine after normal and restricted sleep. Neuropsychopharmacology 1991; 4: 103–8
   PubMed Web of Science ®Google Scholar
• Kelly T, Gomez S, Engelland S, Naitoh P. Repeated administration of caffeine during sleep deprivation does not affect cognitive performance. Sleep Res 1993; 22: 336
   Google Scholar
• Bonnet M H, Arand D L. The use of prophylaptic naps and caffeine to maintain performance during a continuous operation. Ergonomics 1994; 37: 1009–20
   PubMed Web of Science ®Google Scholar
• Robertson D, Curatolo P W. The cardiovascular effects of caffeine. Caffeine, P Dew. Springer-Verlag, New York 1984; 77–85
   Google Scholar
• Yano K, Rhoads G G, Kagan A. Coffee, alcohol and risk of heart coronary disease among Japanese men living in Hawaii. N Engl J Med 1977; 297: 405–9
   PubMed Web of Science ®Google Scholar
• Hughes J, Higgins S, Bickel W, Hunt W, Fenwick J, Gulliver S, Mireault G. Caffeine self-administration, withdrawal and adverse effects amongst coffee drinkers. Arch Gen Psychiatry 1991; 48: 611–7
   PubMed Web of Science ®Google Scholar
• Duteil J, Rambert F A, Pessonnier J, Hernent J F, Gombert R, Assous E. Central alpha 1 adrenergic stimulation in relation to the awakening activity of modafinil: behavioural studies in laboratory animals. Eur J Pharmacol 1990; 180: 49–58
   PubMed Web of Science ®Google Scholar
• Rambert F A, Pessonnier J, Pointeau A M, Bricout D, de Sereville J E, Duteil J. Awakening properties of modafinil: behavioral approach in the mouse. Proceedings: ESRS 5th International Congress of Sleep Research. Copenhagen 1987; 123
   Google Scholar
• Lin J S, Roussel B, Akaoka H, Fort P, Debilly G, Jouvet M. Role of catecholamines in the modafinil and amphetamine induced wakefulness: a comparative pharmacological study in the cat. Brain Res 1992; 591: 319–26
   PubMed Web of Science ®Google Scholar
• Milhaud C, Lagarde D. Effects of Modafinil, an alpha 1 adrenergic type psychostimulant, on the sleep of monkeys. Psychopharmacology 1988; 96: 294
   Google Scholar
• Mignot E, Nishino S, Guilleminault C, Dement W C. Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 1994; 17: 436–7
   PubMed Web of Science ®Google Scholar
• Saletu B, Grunberger J, Linzmayer K, Stohr H. Pharmaco-EEG, psychometric and plasma level studies wim two novel Alpha-adrenergic stimulants CRL 40476 and 40028 (adrafinil) in elderlies. New trends in experimental and clinical psychiatry, P Pancheri, Rome 1986; 5–31
   Google Scholar
• Warot D, Corruble E, Payan C, Weil J S, Puech A J. Subjective effects of Modafinil, a new central adrenergic stimulant in healthy volunteers: a comparison with amphetamine, caffeine and placebo. Eur J Psychiatry 1993; 8: 201–8
   Google Scholar
• Bastuji H, Jouvet M. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuropsychophartnacol Biol Psychiatry 1988; 12: 695–700
   PubMed Web of Science ®Google Scholar
• Besset A, Tafti M, Villemin E, Billiard M. Effects of Modafinil 300 mg on sleep, sleepiness and alerting of narcoleptic subjects. J Sleep Res 1992; 1: 1–23
   Google Scholar
• Billiard M, Besset A, Montplaisir J, Laffont F, Goldenberg F, Weill S S, Lubin S. Modafinil: a double-bind multicentric study. Sleep 1994; 17: S107–S112
   PubMed Web of Science ®Google Scholar
• Laffont F, Mayer G, Minz M. Modafinil in diurnal sleepiness. A study of 123 patients. Sleep 1994; 17: S113–S115
   Google Scholar
• Lagarde D, Milhaud C. Electroencephalographic effects of Modafinil, an alpha 1 adrenergic psychostimulant, on the sleep of rhesus monkey. Sleep 1990; 13: 441–8
   PubMed Web of Science ®Google Scholar
• Duteil J, de Sereville J E, Boer C, Rambert F A. Lack of dopaminergic involvement in modafinil, but not amphetamine and methylphenidate, activity in anaesthetized mice and rats: in vivo voltammetry study. Eur J Pharmacol 1990; 183: 1406–7
   Web of Science ®Google Scholar
• Bensimon J, Benoit O, Lacomblez L, Weiler E, Warot D, Weil J S, Puech A J. Antagonism of modafinil of the psychomotor and cognitive impairment induced by sleep deprivation in 12 healthy volunteers. Psychiatr Psychobiol 1989; 9: 193–254
   Google Scholar
• Batejat D, Lagarde D, Pradella S. Interest of nap and modafinil combination in the reduction of long sleep deprivation effects on psychomotor performance. J Sleep Res 1994; 3: 16
   PubMed Web of Science ®Google Scholar
• Lagarde D, Batejat T. Disrupted sleep-wake rhythm and performance: advantages of Modafinil. Milit Psychol 1994, in press
   Web of Science ®Google Scholar
• Frey R, Saletu B, Anderer P, Krupka M, Grunberger J. Zur Wirkung eines neues zentralen alpha-adrenergen agonisten Modafinil auf die Schlaf und Aufwachquali-tat: vergleichende Schlafslabountersuchung mit D-Amphetamin bei jugenlichen und geriatrischen Probanden. Fortschr Neurol Psychiatr 1988; 56: 174–8
   Google Scholar
• Bastuji H, Jouvet M. Treatment of idiopathic hypersomnia and narcolepsy with CRL 40476. Proceedings; ERS congress. Hungary 1986; 5–11
   Google Scholar
• Laffont F, Cathala H P, Kohler S. Effects of modafinil on narcolepsy and idiopathic hypersomnia. Sleep Res 1987; 16: 377
   Google Scholar
• Goldenberg F, Weil J S, Von Frenckeel R. Effects of Modafinil on diurnal variation of objective sleepiness in normal subjects. Sleep Res 1987; 16: 91
   Google Scholar
• Garma L, Galland Y. Wakefulness-enhancing as a treatment of insomnia and narcolepsy: effects of CRL 4076, an alpha-stimulant medication. Sleep Res 1986; 116: 116
   Google Scholar
• Bourdon L, Jacobs I, Bateman W A, Vallerand A L. Effect of Modafinil on heat production and regulation of body temperatures in cold exposed humans. Aviat Space Environ Med 1994; 65: 999–1004
   PubMedGoogle Scholar
• Orzack M W, Taylor C L, Kornetsky C. A research report on the antifatigue effects of magnesium pemoline. Psychopharmacology 1968; 13: 413–7
   PubMed Web of Science ®Google Scholar
• Elia J. Stimulants and antidepressant pharmacokinetics in hyperactive children. Psy-chopharmacol Bull 1991; 27: 411–5
   PubMed Web of Science ®Google Scholar
• Vermeulen N P, Teunissen M WE, Breimer D D. Pharmacokinetics of pemoline in plasma, saliva and urine following oral administration. Br J Clin Pharmacol 1979; 8: 459–63
   PubMed Web of Science ®Google Scholar
• Nishihara K, Kohda Y, Saitoh Y, Nakagawa F, Honda Y. Determination of pemoline in plasma, plasma water, mixed saliva, and urine by high performance liquid chromatography. Ther Drug Monit 1984; 6: 232–7
   PubMed Web of Science ®Google Scholar
• Sallee F R, Stiller R L, Perel J M. Pharmacodynamics of pemoline in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 1992; 31: 244–51
   PubMed Web of Science ®Google Scholar
• Molina J, Orsinger K. Dopaminergic effects of pemoline. Brain Res 1990; 80: 52–7
   Google Scholar
• Mitler M, Hajdukovic R, Erman M, Koziol J A. Narcolepsy. J Clin Neurophysiol 1990; 7: 93–118
   PubMed Web of Science ®Google Scholar
• Mitler M, Hajdukovic R. Relative efficacy of drugs for the treatment of sleepiness in narcolepsy. Sleep 1991; 14: 218–20
   PubMed Web of Science ®Google Scholar
• Sangal R B, Thomas L. Narcolepsy: improvement in MLST with pemoline. Sleep Res 1994; 22: 320
   Google Scholar
• Gomez S, Kelly T, Schlangen K, Elsmore T, Scott Engelland R. Improvement in cognitive performance after the administration of a single dose of pemoline during a 64-h period without sleep. Sleep Res 1993; 22: 331
   Google Scholar
• Babkoff H, Kelly T L, Matteson L T, Gomez S, Lopez A, Hauser S, Naitoh P. Pemoline and methylphenidate: interaction with mood, sleepiness and cognitive performance during 64 hours of sleep deprivation. Naval Health Research Center, San Diego 1991, Report
   Google Scholar
• Naitoh P, Kelly T L, Babkoff H. Napping, Stimulant, and four-choice performance. Sleep, arousal, and performance, R J Broughton, R D Ogilvie. Birk-hauser, Boston 1992
   Google Scholar
• Nicholson A, Pascoe P A. Dopaminergic transmission and the sleep-wakefulness continuum in man. Neuropharmacology 1989; 29: 411–7
   Web of Science ®Google Scholar
• Sallee F, Stiller R L, Perel J M, Everett G. Pemoline-induced abnormal involuntary movements. J Clin Psychopharmacol 1989; 9: 125–9
   PubMed Web of Science ®Google Scholar
• Pascoe P A, Nicholson A N, Turner C. The use of stimulant drugs in air operations. Conference proceedings: AsMA Scientific Sessions. 1994
   Google Scholar
• Weinshenker B G, Penman M, Bass B, Ebers G C, Rice G PA. A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology 1992; 42: 1468–71
   PubMed Web of Science ®Google Scholar
• Elitsur Y. Pemoline-induced hepatotoxicity. J Pediatr Gastroenterol Nutr 1990; 11: 143–4
   PubMed Web of Science ®Google Scholar